Further research efforts should focus on validating the roles of MYBL2 and the TTRS in larger cohort studies while integrating complementary proteomic and metabolomic approaches to gain a more comprehensive understanding of ovarian cancer biology. Here, MYBL2 is linked to ovarian carcinoma.